Waters Corporation (WAT)
NYSE · Healthcare · Diagnostics & Research
$440.12+3.51%as of Oct 6, 2026, 7:35 AM ET
- Market cap
- $43.2B
- P/E (trailing)
- 111.4
- Forward P/E
- 26.6
- 52-week range
- $282.77 – $448.21
- 52-week change
- +33.57%
- EPS (trailing)
- $3.95
- Analyst rating
- 1.6 Buy
- Next earnings
- Nov 3, 2026
Fiscal year to Dec 2025
- Revenue
- $3.2B (+6.99%)
- Net income
- $643M
- Operating margin
- 25.4%
- Diluted EPS
- $10.76
- Free cash flow
- $540M
From the company’s annual report on SEC EDGAR.
About Waters Corporation
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing.
Headquarters: Milford, United States · 16,000 employees · waters.com